1.

Lyme borreliosis in Belgium : a cost-of-illness analysis

2.

Lyme borreliosis in Belgium : a cost-of-illness analysis

3.

Lyme borreliosis in Belgium : a cost-of-illness analysis

4.

Lyme borreliosis in Belgium : a cost-of-illness analysis

5.

Lyme borreliosis in Belgium : a cost-of-illness analysis

1.

The association between area deprivation and COVID-19 incidence : a municipality-level spatio-temporal study in Belgium, 2020–2021

2.

The association between area deprivation and COVID-19 incidence : a municipality-level spatio-temporal study in Belgium, 2020–2021

3.

The association between area deprivation and COVID-19 incidence : a municipality-level spatio-temporal study in Belgium, 2020–2021

1.

Public Health Impact of Congenital Toxoplasmosis and Cytomegalovirus Infection in Belgium, 2013: A Systematic Review and Data Synthesis

2.

Public Health Impact of Congenital Toxoplasmosis and Cytomegalovirus Infection in Belgium, 2013: A Systematic Review and Data Synthesis

3.

Public Health Impact of Congenital Toxoplasmosis and Cytomegalovirus Infection in Belgium, 2013: A Systematic Review and Data Synthesis

1.

The association between area deprivation and COVID-19 incidence: a municipality-level spatio-temporal study in Belgium, 2020–2021

1.

Correction to: The association between area deprivation and COVID-19 incidence: a municipality-level spatio-temporal study in Belgium, 2020–2021

1.

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015

2.

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015

3.

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015

4.

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015

5.

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015

6.

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015

7.

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015

8.

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015

1.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

2.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

3.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

4.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

5.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

6.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

7.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

8.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

9.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

1.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

2.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

3.

Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015–2017

1.

Intake of fat-soluble vitamins in the Belgian population : adequacy and contribution of foods, fortified foods and supplements

1.

Quantifying burden of disease to support public health policy in Belgium : opportunities and constraints

2.

Quantifying burden of disease to support public health policy in Belgium : opportunities and constraints

3.

Quantifying burden of disease to support public health policy in Belgium : opportunities and constraints

4.

Quantifying burden of disease to support public health policy in Belgium : opportunities and constraints

5.

Quantifying burden of disease to support public health policy in Belgium : opportunities and constraints